Bulk and single-cell RNA-seq data were collected and analyzed from multiple studies and cancer types, and results showed that a single IFN-α/β/IFN-γ/IL-15 pathway could predict clinical responses and survival to ICB. This evidence concerns the gene IFNA1 and cancer.